Purpose: Nodal metastasis is the main prognostic factor in the patients with oral squamous cell carcinoma (OSCC). We investigated the association between tumor-associated lymphatics and OSCC characteristics. Methods: Thirty-four specimens were used for the immunohistochemical staining with the antibody for vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGF receptor (VEGFR)-3, phosphorylated VEGFR-3, D2-40, and matrix metallproteinases (MMPs). We observed the distribution of the lymphangiogenic factors and quantified the degree of expression. We determined lymphatic vessel density (LVD) and lymphatic vessel dilatation with D2-40 immunostaining. We assessed the association of LVD or lymphatic vessel dilatation with tumor progression or tumor differentiation. Results: OSCC cells expressed lymphangiogenic ligands. Lymphangiogenic receptor, VEGFR-3, was expressed and activated in some tumor cells as well as in tumor-associated endothelial cells. LVD was not associated with tumor size or nodal status, but lymphatic vessel dilatation was higher in tumors with nodal metastasis, and also higher in poorly differentiated tumors. In stromal area of OSCC, MMP-1 and MMP-10 were up-regulated and the basement membrane of tumor-associated endothelial cells was destroyed by these collagenases. Conclusion: In the primary tumors with nodal metastasis, especially in poorly differentiated OSCC, tumor cells invaded the dilated lymphatic vessels via ruptured sites. MMP-1 and MMP-10 are important in the lysis of the glycocalyx inside the tumor-associated lymphatic endothelial cells.
Introduction
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Among several lymphangiogenic factors, the vascular endothelial growth factor (VEGF)-C, D/VEGFR-3 signaling pathway is the most powerful stimulant for the genesis of tumor-associated lymphatics [8] . Research shows an association of VEGF-C/VEGFR-3 axis with lymphatic spread of tumor cells and with clinical outcomes in solid tumors including oral squamous cell carcinoma (OSCC) [9] [10] [11] .
The main hypothesis of this study is that lymphangiogenic factor levels are higher in the primary tumor with nodal metastasis than in the primary tumor without nodal metastasis in OSCC. Thus we assessed the association of tumor-associated lymphatics with tumor proliferation or nodal metastasis or tumor differentiation.
Materials and Methods

Patients and tumor specimens
Thirty-four surgical specimens were collected from pa- MMPs staining was performed as above.
Immunohistochemistry
Quantitative immunohistochemical analysis
Tissue-slides were observed with a microscope camera (Olympus DP70 digital microscope camera; Olympus Co., Tokyo, Japan). Images were taken from two representative areas per specimen under ×100 magnification. The images were blindly assessed to prevent area bias. To quantify the expression of each protein, an image analysis program (SigmaScan Pro 5.0; SPSS Science, Chicago, IL, USA) was used. The expression level was measured by the numbers of pixels that appeared red by this program. The average percent of the ratio of red pixels to total pixels was used as a measure of protein expression for each specimen.
Lymphatic vessel density and lymphatic vessel dilatation
Lymphatic vessel density (LVD) and lymphatic vessel dilatation were determined with immunostaining with D2-40. To determine LVD, the sections were scanned by light microscopy at a low magnification (×100). We identified the area of the greatest number of lymph vessels each in intratumoral and peritumoral area. LVD was then determined by counting immunostained vessels that have lumina at higher magnification (×200). Counts were performed blindly by two investigators. The frequency of lymphatic vessel dilation was determined by an oral pathologist from the same fields.
Statistics
The association between expressions of the lymphangio- 
Results
Histopathology
Classification by tumor size resulted in four OSCC as T1, 17 OSCC as T2, five OSCC as T3, and eight OSCC (Fig. 1) . However, the degree of VEGFR-3 or pVEGFR-3 expression was not related to the tumor size or nodal metastasis (data not shown). pVEGFR-3 expression was significantly higher in the poorly differentiated tumors ( Table 2 ).
Lymphatic vessel density and lymphatic vessel dilatation
D2-40 was specifically expressed in the endothelial cells of tumor-associated lymphatic vessels. D2-40 positive lymphatic vessels were present in all OSCCs. The stained vessels were devoid of red blood cells, and D2-40 was restricted to the endothelium not only at the peritumoral lesion but also at the intratumoral lesion. Peritumoral LVD was higher than intratumoral LVD (Fig. 2) . We could detect lymphatic vessel dilation and rupture in peritumoral lymphatics, but not in intratumoral lymphatics (Fig. 3 ).
Lymphatic vessel density vs. oral squamous cell carcinoma progression or differentiation
To assess the association between LVD and OSCC progression, the tumors were divided into two groups by primary tumor size at 4 cm. LVD was not associated with tumor size or nodal status (Table 3) . Table 4 shows that higher peritumoral lymphatic vessel dilation values were associated with significantly high scores of N-classification (P ＜0.05). Moreover, in peritumoral lymphatics, higher lymphatic vessel dilation values were also associated with significantly high proportions of poorly differentiated tumors (Table 5 ).
Lymphatic vessel dilation vs. oral squamous cell carcinoma progression or differentiation
Matrix metallproteinases expression in oral squamous cell carcinoma
We immunostained the specimens with four tissue colla- OSCC is characterized by aggressive biological behavior with a low five-year survival rate, mainly due to cervical node metastasis [12] . Lymphangiogenic factors are related to cervical nodal metastasis and VEGFR-C is a main stimulator of lymphangiogenesis [13] [14] [15] . Tsirlis et al. [16] Morphologically, intratumoral lymphatics are compressed, seemingly nonfunctional.
Podoplanin (D2-40) expression in OSCC may be related to its progression [24, 25] , but our previous study demonstrated that the number of microvessels rather than podoplanin expression was indicative of OSCC progression [26] .
In the present study, LVD evaluation revealed that peritumoral LVD and intratumoral LVD are not significantly asso- Sedivy et al. [27] reported that LVD is positively associated with VEGF-C expression and nodal metastasis in OSCC, but we could not reach such a conclusion. This We need more controlled further study.
Conclusion
In conclusion, this study indicates that increased dilation of tumor-associated lymphatic vessels is significantly related to nodal metastasis. Furthermore, OSCC tumor cells invaded the ruptured site of the dilated lymphatics, apparently mediated by MMP-1 and MMP-10. In sum, peritumoral lymphatic dilatation may be an important step in the cervical nodal metastasis of oral squamous cell carcinoma. We suggest that newly formed lymphatics inside the tumor are a target for anti-metastasis therapy of OSCC.
